Literature DB >> 17531616

IUDs and colonization or infection with Actinomyces.

Carolyn Westhoff1.   

Abstract

Pelvic actinomycosis is an extremely rare disease that can occur in women with a long duration of intrauterine device (IUD) use. This type of abscess is usually unsuspected and, thus, diagnosed and treated surgically; however, long-duration treatment with penicillin can be completely effective. While the occurrence of actinomycosis is well documented by case reports, it is not possible to quantify the risk during IUD use. Approximately 7% of women using an IUD may have a finding of Actinomyces-like organisms on a Pap test. The prognostic significance of this finding is minimal because of the lack of sensitivity and specificity and a low positive predictive value. In the absence of symptoms, women with Actinomyces-like organisms on a Pap test do not need antimicrobial treatment or IUD removal.

Entities:  

Mesh:

Year:  2007        PMID: 17531616     DOI: 10.1016/j.contraception.2007.01.006

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  12 in total

1.  Actinomyces urogenitalis bacteremia and tubo-ovarian abscess after an in vitro fertilization (IVF) procedure.

Authors:  Frederik Van Hoecke; Ellen Beuckelaers; Peter Lissens; Michael Boudewijns
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

2.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 3.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Actinomyces in explanted transvaginal mesh: commensal or pathogen?

Authors:  Susana Mustafa Mikhail; Peta Fairweather; Anna Eastman; Gunter Hartel; Zhuoran Chen; Christopher Maher
Journal:  Int Urogynecol J       Date:  2021-01-08       Impact factor: 2.894

5.  Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia.

Authors:  Carolyn M Yu Wu; Amanda Noska
Journal:  BMJ Case Rep       Date:  2016-03-10

Review 6.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

7.  Actinomyces-like organisms in cervical smears: the association with intrauterine device and pelvic inflammatory diseases.

Authors:  Yeo Joo Kim; Jina Youm; Jee Hyun Kim; Byung Chul Jee
Journal:  Obstet Gynecol Sci       Date:  2014-09-17

8.  Differentiating pelvic actinomycosis from advanced ovarian cancer: a report of two cases, management reflections and literature review.

Authors:  Alex Laios; Iryna Terekh; Hooman Soleymani Majd; Pubudu Pathiraja; Sanjiv Manek; Krishnayan Haldar
Journal:  Gynecol Oncol Res Pract       Date:  2014-12-10

9.  A Complicated Thread: Abdominal Actinomycosis in a Young Woman with Crohn Disease.

Authors:  Ari Nahum; Gregory Filice; Ashish Malhotra
Journal:  Case Rep Gastroenterol       Date:  2017-06-14

10.  The presence of eosinophil leucocytes in cervicovaginal smears with Actinomyces-like organisms: Light microscopic examination.

Authors:  Dilek Kaya; Sayeste Demirezen; Mehmet Sinan Beksaç
Journal:  J Cytol       Date:  2012-10       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.